FI108229B - Menetelmä farmaseuttisesti käyttökelpoisten pyridopyridatsinoni- ja -pyridatsiinitioniyhdisteiden valmistamiseksi - Google Patents
Menetelmä farmaseuttisesti käyttökelpoisten pyridopyridatsinoni- ja -pyridatsiinitioniyhdisteiden valmistamiseksi Download PDFInfo
- Publication number
- FI108229B FI108229B FI941567A FI941567A FI108229B FI 108229 B FI108229 B FI 108229B FI 941567 A FI941567 A FI 941567A FI 941567 A FI941567 A FI 941567A FI 108229 B FI108229 B FI 108229B
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- formula
- hydrogen
- nitro
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77567991A | 1991-10-09 | 1991-10-09 | |
US77567991 | 1991-10-09 | ||
US9208398 | 1992-10-08 | ||
PCT/US1992/008398 WO1993007146A1 (en) | 1991-10-09 | 1992-10-08 | Benzo and pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
Publications (3)
Publication Number | Publication Date |
---|---|
FI941567A FI941567A (fi) | 1994-04-06 |
FI941567A0 FI941567A0 (fi) | 1994-04-06 |
FI108229B true FI108229B (fi) | 2001-12-14 |
Family
ID=25105161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI941567A FI108229B (fi) | 1991-10-09 | 1994-04-06 | Menetelmä farmaseuttisesti käyttökelpoisten pyridopyridatsinoni- ja -pyridatsiinitioniyhdisteiden valmistamiseksi |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0612321B1 (ko) |
JP (1) | JP3245165B2 (ko) |
KR (1) | KR100263494B1 (ko) |
AT (1) | ATE183745T1 (ko) |
AU (1) | AU670544B2 (ko) |
CA (1) | CA2117059C (ko) |
DE (1) | DE69229874T2 (ko) |
DK (1) | DK0612321T3 (ko) |
ES (2) | ES2135416T3 (ko) |
FI (1) | FI108229B (ko) |
GR (1) | GR3030969T3 (ko) |
HU (2) | HUT66969A (ko) |
IL (1) | IL103388A (ko) |
MX (1) | MX9205794A (ko) |
NO (1) | NO302888B1 (ko) |
NZ (1) | NZ244660A (ko) |
PT (1) | PT100938B (ko) |
TW (1) | TW365606B (ko) |
WO (1) | WO1993007146A1 (ko) |
ZA (1) | ZA927755B (ko) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9200689D0 (en) * | 1992-01-14 | 1992-03-11 | Rhone Poulenc Agriculture | New compositions of matter |
GB9314412D0 (en) * | 1993-07-13 | 1993-08-25 | Rhone Poulenc Agriculture | New compositions of matter |
US5665754A (en) * | 1993-09-20 | 1997-09-09 | Glaxo Wellcome Inc. | Substituted pyrrolidines |
US5466697A (en) * | 1994-07-13 | 1995-11-14 | Syntex (U.S.A.) Inc. | 8-phenyl-1,6-naphthyridin-5-ones |
US5817670A (en) * | 1994-08-29 | 1998-10-06 | Yamanouchi Pharmaceutical Co., Ltd. | Naphthyridine derivatives and pharmaceutical compositions thereof |
GB9712761D0 (en) * | 1997-06-17 | 1997-08-20 | Chiroscience Ltd | Quinolines and their therapeutic use |
US6069151A (en) * | 1996-11-06 | 2000-05-30 | Darwin Discovery, Ltd. | Quinolines and their therapeutic use |
ES2137113B1 (es) * | 1997-07-29 | 2000-09-16 | Almirall Prodesfarma Sa | Nuevos derivados de triazolo-piridazinas heterociclicos. |
AU753576B2 (en) * | 1997-12-15 | 2002-10-24 | Altana Pharma Ag | Dihydrobenzofurans |
EP0934933A1 (en) * | 1998-02-06 | 1999-08-11 | Byk Gulden Lomberg Chemische Fabrik GmbH | Phthalazinones |
IT1303272B1 (it) * | 1998-10-29 | 2000-11-06 | Zambon Spa | Derivati triciclici inibitori della fosfodiesterasi 4 |
UA71945C2 (en) | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
JP3270834B2 (ja) | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
AU777012B2 (en) | 1999-08-21 | 2004-09-30 | Takeda Gmbh | Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist |
NZ527424A (en) * | 2001-02-15 | 2005-02-25 | Altana Pharma Ag | Phthalayinone-piperidino-derivatives as PDE4 inhibitors |
NZ529363A (en) | 2001-04-25 | 2005-08-26 | Altana Pharma Ag | Novel Piperazino-derivatives |
CN1503792A (zh) | 2001-04-25 | 2004-06-09 | ��̹��ҽҩ��˾ | 新的酞嗪酮 |
ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
EP1542987A1 (en) * | 2002-08-10 | 2005-06-22 | ALTANA Pharma AG | Piperidine-n-oxide-derivatives |
AU2003260376A1 (en) | 2002-08-10 | 2004-03-11 | Altana Pharma Ag | Piperidine-pyridazones and phthalazones as pde4 inhibitors |
ES2211344B1 (es) * | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
AU2004226353A1 (en) | 2003-04-01 | 2004-10-14 | Laboratoires Serono Sa | Inhibitors of phosphodiesterases in infertility |
WO2005075456A1 (en) | 2004-02-04 | 2005-08-18 | Altana Pharma Ag | 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
PL383550A1 (pl) * | 2007-10-15 | 2009-04-27 | Uniwersytet Łódzki | Nowe pochodne benzeno- i pirydopirydazynonów |
EP2328910B1 (en) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA3100941C (en) | 2011-03-01 | 2024-03-05 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
US20130116241A1 (en) | 2011-11-09 | 2013-05-09 | Abbvie Inc. | Novel inhibitor compounds of phosphodiesterase type 10a |
WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
CA2906008C (en) | 2013-03-13 | 2019-07-09 | Flatley Discovery Lab, Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
KR102456567B1 (ko) | 2013-08-09 | 2022-10-19 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
EP3265453B1 (en) * | 2015-03-05 | 2022-06-29 | Boehringer Ingelheim International GmbH | New pyridinones and isoquinolinones as inhibitors of the bromodomain brd9 |
JP6837052B2 (ja) * | 2016-03-09 | 2021-03-03 | 日本曹達株式会社 | ピリジン化合物およびその用途 |
LT3442972T (lt) | 2016-04-15 | 2020-06-10 | Abbvie Inc. | Bromodomeno inhibitoriai |
EP3972599A1 (en) | 2019-05-21 | 2022-03-30 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
FR3105254B1 (fr) | 2019-12-19 | 2022-08-12 | Syctom Lagence Metropolitaine Des Dechets Menagers | Installation et procédé de gazéification hydrothermale de biomasse |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2805344B2 (ja) * | 1989-07-11 | 1998-09-30 | 昭和電工株式会社 | オレフィン重合触媒の製造方法およびオレフィンの重合方法 |
WO1991012251A1 (en) * | 1990-02-19 | 1991-08-22 | Chugai Seiyaku Kabushiki Kaisha | Novel fused heterocyclic compound and antiasthmatic agent prepared therefrom |
-
1992
- 1992-10-08 ES ES92922090T patent/ES2135416T3/es not_active Expired - Lifetime
- 1992-10-08 JP JP50707893A patent/JP3245165B2/ja not_active Expired - Fee Related
- 1992-10-08 TW TW081108015A patent/TW365606B/zh active
- 1992-10-08 KR KR1019940701129A patent/KR100263494B1/ko not_active IP Right Cessation
- 1992-10-08 WO PCT/US1992/008398 patent/WO1993007146A1/en active IP Right Grant
- 1992-10-08 AU AU27815/92A patent/AU670544B2/en not_active Ceased
- 1992-10-08 IL IL103388A patent/IL103388A/xx not_active IP Right Cessation
- 1992-10-08 MX MX9205794A patent/MX9205794A/es not_active IP Right Cessation
- 1992-10-08 NZ NZ244660A patent/NZ244660A/en unknown
- 1992-10-08 CA CA002117059A patent/CA2117059C/en not_active Expired - Fee Related
- 1992-10-08 ES ES09201998A patent/ES2105920B1/es not_active Expired - Fee Related
- 1992-10-08 PT PT100938A patent/PT100938B/pt not_active IP Right Cessation
- 1992-10-08 DK DK92922090T patent/DK0612321T3/da active
- 1992-10-08 DE DE69229874T patent/DE69229874T2/de not_active Expired - Fee Related
- 1992-10-08 ZA ZA927755A patent/ZA927755B/xx unknown
- 1992-10-08 EP EP92922090A patent/EP0612321B1/en not_active Expired - Lifetime
- 1992-10-08 HU HU9400949A patent/HUT66969A/hu unknown
- 1992-10-08 AT AT92922090T patent/ATE183745T1/de not_active IP Right Cessation
-
1994
- 1994-04-05 NO NO941210A patent/NO302888B1/no not_active IP Right Cessation
- 1994-04-06 FI FI941567A patent/FI108229B/fi active
-
1995
- 1995-04-24 HU HU95P/P00113P patent/HU210814A9/hu unknown
-
1999
- 1999-08-26 GR GR990401632T patent/GR3030969T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU670544B2 (en) | 1996-07-25 |
JP3245165B2 (ja) | 2002-01-07 |
FI941567A (fi) | 1994-04-06 |
ATE183745T1 (de) | 1999-09-15 |
HUT66969A (en) | 1995-01-30 |
ES2135416T3 (es) | 1999-11-01 |
CA2117059A1 (en) | 1993-04-15 |
PT100938A (pt) | 1993-10-29 |
CA2117059C (en) | 2003-05-20 |
ES2105920B1 (es) | 1998-07-01 |
PT100938B (pt) | 1999-10-29 |
IL103388A (en) | 1997-09-30 |
EP0612321A1 (en) | 1994-08-31 |
NO941210L (no) | 1994-04-05 |
DK0612321T3 (da) | 1999-12-13 |
ES2105920A1 (es) | 1997-10-16 |
HU9400949D0 (en) | 1994-06-28 |
NO302888B1 (no) | 1998-05-04 |
WO1993007146A1 (en) | 1993-04-15 |
ZA927755B (en) | 1994-04-08 |
KR100263494B1 (ko) | 2000-08-01 |
HU210814A9 (en) | 1995-08-28 |
IL103388A0 (en) | 1993-03-15 |
GR3030969T3 (en) | 1999-11-30 |
JPH07500321A (ja) | 1995-01-12 |
EP0612321B1 (en) | 1999-08-25 |
AU2781592A (en) | 1993-05-03 |
FI941567A0 (fi) | 1994-04-06 |
MX9205794A (es) | 1993-04-01 |
DE69229874T2 (de) | 1999-12-09 |
NO941210D0 (no) | 1994-04-05 |
NZ244660A (en) | 1995-05-26 |
DE69229874D1 (de) | 1999-09-30 |
KR940702868A (ko) | 1994-09-17 |
TW365606B (en) | 1999-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI108229B (fi) | Menetelmä farmaseuttisesti käyttökelpoisten pyridopyridatsinoni- ja -pyridatsiinitioniyhdisteiden valmistamiseksi | |
FI106960B (fi) | Menetelmä terapeuttisesti aktiivisten 1-fenyyli-pyrido[2,3-d]pyrimidiini-2,4-dioni- ja 2-onijohdannaisten valmistamiseksi | |
AU754734B2 (en) | Indazole bioisostere replacement of catechol in therapeutically active compounds | |
JP3270830B2 (ja) | 化合物 | |
DE60221098T2 (de) | Kondensierte heterocyclische derivate | |
AU2007292155B2 (en) | Imidazole derivative | |
JP7191826B2 (ja) | 三環式rhoキナーゼ阻害剤 | |
ES2548882T3 (es) | Moduladores del receptor de prostaciclina (PGl2) útiles para el tratamiento de trastornos relacionados con los mismos | |
JP2015134805A (ja) | Nadphオキシダーゼインヒビターとしてのピラゾロピリジン誘導体を含有する医薬組成物 | |
JP2008503531A (ja) | ピリダジン−3(2h)−オン誘導体およびpde4の阻害剤としてのそれらの使用 | |
JP2005506350A (ja) | サイトカイン阻害薬としての1,4−二置換ベンゾ−縮合尿素化合物 | |
EA011634B1 (ru) | 3-[4-гетероциклил-1,2,3-триазол-1-ил]-n-арилбензамиды в качестве ингибиторов продуцирования цитокинов, предназначенные для лечения хронических воспалительных заболеваний | |
NO873432L (no) | Fremgangsmaate for fremstilling av imidazolforbindelser. | |
EA027244B1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
MXPA05007407A (es) | Derivados de urea ciclica, su preparacion y su utilizacion farmaceutica como inhibidores de quinasas. | |
KR20130089245A (ko) | 1-페닐-치환된 헤테로시클릴 유도체 및 프로스타글란딘 d2 수용체 조절자로서 이의 용도 | |
US20080176894A1 (en) | Novel aminopyridine-derivatives | |
CA3128846A1 (en) | Difluoromethylene compound | |
BRPI0921369B1 (pt) | Composto modulador do receptor de prostaciclina (pgi2), sua composição, sua composição farmacêutica, seus usos, bem como processos para a preparação das referidas composições | |
JP2898256B2 (ja) | 特定の4−アリール−5−カルバモイル−1,4−ジヒドロピリジンを含む医薬組成物 | |
JPWO2003004497A1 (ja) | 新規複素環化合物 | |
JP2006519798A (ja) | 5HT2c受容体に活性を有する化合物及びその使用 | |
RU2676332C1 (ru) | Способ получения 3-замещённых сложных эфиров (индол-1-ил)-уксусной кислоты | |
KR20070107082A (ko) | 2-설피닐- 및 2-설포닐-치환 이미다졸 유도체 및 시토킨억제제로서의 그들의 용도 | |
EP2888261B1 (en) | Antagonists of chemokine receptors |